H. E. Kaiser
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
-
- Cell Adhesion Molecules Research
Papers in
- Oncology 10
- Cancer Diagnosis and Treatment 5
- Cancer Cells and Metastasis 2
-
- Neuroblastoma Research and Treatments 4
- Co-authors
- B Bödey (10 shared papers)Stuart E. Siegel (8 shared papers)Klaus Kaserer (1 shared paper)NIKOLAUS NEUHOLD (2 shared papers)A M Gröger (3 shared papers)Arwa K. Nasir (1 shared paper)James V. Luck (1 shared paper)Charlotte R. Taylor (1 shared paper)
- Journals
- Endocrine Pathology (1 paper)PubMed (17 papers)
- Partner nations
- United StatesAustriaGermany
In The Last Decade
H. E. Kaiser
28 papers receiving 436 citations
Peers
Comparison fields: 5 of 67
- Endocrinology, Diabetes and Metabolism 86
- Immunology and Allergy 22
- Oncology 89
- Cancer Research 45
- Hepatology 22
Countries citing papers authored by H. E. Kaiser
This map shows the geographic impact of H. E. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. Kaiser more than expected).
Fields of papers citing papers by H. E. Kaiser
This network shows the impact of papers produced by H. E. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. Kaiser. The network helps show where H. E. Kaiser may publish in the future.
Co-authors
The 25 scholars most cited alongside H. E. Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. | 1997 | 57 |
| 2 | 2001 | 53 | |
| 3 | Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma. | 1998 | 47 |
| 4 | Novel insights into the function of the thymic Hassall's bodies. | 2000 | 36 |
| 5 | Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review. | 2000 | 36 |
| 6 | Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. | 1998 | 36 |
| 7 | Apoptosis and pathogenesis of viral hepatitis C--an update. | 2000 | 36 |
| 8 | Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors. | 2000 | 31 |
| 9 | Development of Hassall's bodies of the thymus in humans and other vertebrates (especially mammals) under physiological and pathological conditions: immunocytochemical, electronmicroscopic and in vitro observations. | 1997 | 26 |
| 10 | Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva. | 2004 | 21 |
| 11 | Identification of neural crest derived cells within the cellular microenvironment of the human thymus employing a library of monoclonal antibodies raised against neuronal tissues. | 1996 | 15 |
| 12 | Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors. | 2000 | 12 |
| 13 | Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus. | 2001 | 8 |
| 14 | Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression. | 1997 | 6 |
| 15 | Advances in the understanding of lung cancer. | 1997 | 6 |
| 16 | Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors. | 1997 | 5 |
| 17 | 1989 | 5 | |
| 18 | 1989 | 3 | |
| 19 | 1989 | 3 | |
| 20 | Development of Organotypic Cancer Models for the Identification of Individualized Cancer Therapies | 2016 | 2 |
About H. E. Kaiser
H. E. Kaiser is a scholar working on Oncology, Neurology, Genetics, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 30 papers that have together received 453 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (4 papers), Glioma Diagnosis and Treatment (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Nutrition, Genetics, and Disease (2 papers), Microtubule and mitosis dynamics (2 papers), Hedgehog Signaling Pathway Studies (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (86 citations), Immunology and Allergy (22 citations), Oncology (89 citations), Cancer Research (45 citations) and Hepatology (22 citations). H. E. Kaiser has collaborated with scholars based in United States, Austria and Germany. Frequent co-authors include B Bödey, Stuart E. Siegel, Klaus Kaserer, NIKOLAUS NEUHOLD, A M Gröger, Arwa K. Nasir, James V. Luck, Charlotte R. Taylor, Aqsa Nasir and Jennifer Z. Gillespie. Their work appears in journals such as Endocrine Pathology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.